Building upon over 30 years of medical innovation, 3CPM pioneered the future of Electrogastrography (EGG) through miniaturized hardware and patented, AI-driven software.
Our non-invasive, 45-minute diagnostic test provides accurate, real-time data to help clinicians objectively characterize complex gastrointestinal motility disorders—including gastroparesis, functional dyspepsia, reflux, and chronic bloating. By subtyping myoelectrical activity, 3CPM enables personalized diagnoses and targeted treatment pathways to optimize patient outcomes and resolve previously untreatable illnesses.